Researcher
Maarten Jacquemyn
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From10 Aug 2009 → Today
Publications
1 - 10 of 20
- Corrigendum to "Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells" [Biochem. Pharmacol. 227 (2024) 116445].(2024)
Authors: Maarten Jacquemyn, Dirk Daelemans, Pieter Annaert
Pages: 116497 - The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance.(2024)
Authors: Maarten Jacquemyn, Dirk Daelemans, Dominique Schols
Pages: 362 - Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy.(2024)
Authors: Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Rosa Trotta, Samantha Pretto, Shikang Zhao, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Susan Schlenner, et al.
Pages: eadm8660 - TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry(2023)
Authors: Jim Baggen, Maarten Jacquemyn, Els Vanstreels, Hendrik Jan Thibaut, Piet Maes, Dirk Daelemans
Pages: 3427 - + - CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity(2023)
Authors: Wenting Guo, Elke Braems, Pegah Masrori, Evelien Van Schoor, Maarten Jacquemyn, Sriram Balusu, Tine Tricot, Pieter Vanden Berghe, Dietmar Thal, Rik Vandenberghe, et al.
Pages: 1245 - 1259 - CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids(2023)
Authors: Hui Yang, Mikhail Abramov, Maarten Jacquemyn, Elisabetta Groaz, Dirk Daelemans, Piet Herdewyn
Pages: 1501 - 1511 - The material properties of a bacterial-derived biomolecular condensate tune biological function in natural and synthetic systems(2022)
Authors: Maarten Jacquemyn, Dirk Daelemans
- Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2(2021)
Authors: Jim Baggen, Els Vanstreels, Sander Jansen, Bram Boeckx, Vincent Geudens, Dirk Jochmans, Joost Wauters, Els Wauters, Bart Vanaudenaerde, Diether Lambrechts, et al.
Pages: 435 - + - Loss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis(2021)
Authors: Maarten Jacquemyn, Dirk Daelemans
- XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis(2021)
Authors: Tim Dierckx, Soraya Menezes, Maarten Jacquemyn, Robert Snoeck, Graciela Andrei, Johan Van Weyenbergh, Dirk Daelemans